ISL1 Promotes Enzalutamide Resistance in Castration-Resistant Prostate Cancer (CRPC) through Epithelial to Mesenchymal Transition (EMT)

The authors revealed the important role of insulin gene enhancer-binding protein 1 (ISL1) in androgen receptor (AR)-dependent prostate cancer cell growth; ISL1 knockdown reduced the AR activity and cell growth.